AC Immune SA (ACIU)
NASDAQ: ACIU · Real-Time Price · USD
3.310
-0.090 (-2.65%)
Oct 8, 2024, 4:00 PM EDT - Market closed
AC Immune Employees
As of December 31, 2023, AC Immune had 161 total employees, including 133 full-time and 28 part-time employees. The number of employees increased by 5 or 3.21% compared to the previous year.
Employees
161
Change (1Y)
5
Growth (1Y)
3.21%
Revenue / Employee
$107,054
Profits / Employee
-$418,242
Market Cap
327.49M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Viemed Healthcare | 996 |
Treace Medical Concepts | 516 |
Fate Therapeutics | 181 |
Nautilus Biotechnology | 167 |
Nano-X Imaging | 164 |
iTeos Therapeutics | 157 |
Inozyme Pharma | 59 |
Artiva Biotherapeutics | 43 |
ACIU News
- 2 months ago - AC Immune Unveils Novel Therapeutic Antibody Drug Conjugate (ADC) Technology for Improved Efficacy in Neurodegenerative Diseases at AAIC 2024 - GlobeNewsWire
- 2 months ago - AC Immune: Takeda Partnership Brings Funds To Drive Pipeline Forward - Seeking Alpha
- 2 months ago - AC Immune's ACI-35.030 (now “JNJ-2056”) Granted FDA Fast Track Designation for Alzheimer's Disease - GlobeNewsWire
- 4 months ago - AC Immune to Present at the Jefferies Global Healthcare Conference in June 2024 - GlobeNewsWire
- 5 months ago - Alzheimer's vaccine licensing deal boosts AC Immune - Market Watch
- 5 months ago - AC Immune Reports First Quarter 2024 Financial Results and Provides a Corporate Update - GlobeNewsWire
- 5 months ago - AC Immune and Takeda Sign Exclusive Option and License Agreement for Active Immunotherapy Targeting Amyloid Beta for Alzheimer's Disease - Business Wire
- 7 months ago - AC Immune Reports Full Year 2023 Financial Results and Provides a Corporate Update - GlobeNewsWire